| Unique ID issued by UMIN | UMIN000053770 |
|---|---|
| Receipt number | R000061362 |
| Scientific Title | Verification of the effect of taking supplement containing lactic acid bacteria on the oral environment: randomized, placebo-controlled, double-blind, parallel-group comparison trial |
| Date of disclosure of the study information | 2025/04/07 |
| Last modified on | 2024/03/04 11:24:14 |
Verification of the effect of taking supplement containing lactic acid bacteria on the oral environment
Supplement containing lactic acid bacteria intake test
Verification of the effect of taking supplement containing lactic acid bacteria on the oral environment: randomized, placebo-controlled, double-blind, parallel-group comparison trial
Supplement containing lactic acid bacteria intake test: randomized, placebo-controlled, double-blind, parallel-group comparison trial
| Japan |
Healthy adult
| Not applicable | Adult |
Others
NO
Verification of the effect of taking supplement containing lactic acid bacteria on the oral environment
Efficacy
Confirmatory
Gingival index
Bleeding of probing
Measurement of Gingipain (Periodontal Pathogen)
Question paper
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
YES
NO
Institution is not considered as adjustment factor.
YES
No need to know
2
Prevention
| Food |
To intake supplements containing lactic acid bacteria 1 tablets / day for 4 weeks.
To intake placebo 1 tablets / day for 4 weeks.
| 40 | years-old | <= |
| Not applicable |
Male and Female
(1) Persons who are 40 years old or older
(2) Persons who are generally judged as healthy
(3) Persons who can give voluntary written consent to participate in the present trial
(1) persons who have any dietary supplements, quasi drugs or medicines which cause same or similar efficacy with the effect evaluated in this study
(2) persons who have changed their habitats to take supplements within past 4 weeks.
(3) Persons who work in night shift or in day and night shift
(4) persons who have been treated their illness or prevention in a clinic at their informed consent
(5) persons with their medical histories as follows: serious diseases of sugar metabolism, lipid metabolism, hepatic function, renal function, heart, circulatory, respiratory, endocrine system, immune system, or mental illness of the nervous system
(6) persons with the medical histories of alcoholism or drug dependence
(7) persons who might be developed allergic reaction to foods.
(8) Persons who are pregnant, breast-feeding, or hope to be pregnant during the study period
(9) persons who had always participated in or will participate in any other clinical trial (to use foods/medicine/quasi medicine/medical device)
(10) persons who will not be judged suitable to the participants by the investigator.
40
| 1st name | Ohnuki |
| Middle name | |
| Last name | Kouichirou |
Kindai University
Faculty of humanity-oriented science and engineering
820-0011
11-6,Kayanomori,Iiduka-shi,Fukuoka,Japan
0948-22-5655
ohnuki@fuk.kindai.ac.jp
| 1st name | Ohnuki |
| Middle name | |
| Last name | Keiko |
User Life Science Co.,Ltd.
The research and development part
820-0115
372-3,Niho,Iiduka-shi,Fukuoka,Japan
0948-82-3123
userlifescience@gmail.com
User Life Science Co.,Ltd.
Bizen Chemical Co.,Ltd.
Profit organization
Kindai University, Faculty of humanity-oriented science and engineering, Ethics Committee
11-6,Kayanomori,Iiduka-shi,Fukuoka,Japan
0948-22-5655
ohnuki@fuk.kindai.ac.jp
NO
RECO舞鶴(福岡県)
| 2025 | Year | 04 | Month | 07 | Day |
Unpublished
41
No longer recruiting
| 2024 | Year | 02 | Month | 14 | Day |
| 2023 | Year | 03 | Month | 23 | Day |
| 2024 | Year | 03 | Month | 09 | Day |
| 2024 | Year | 04 | Month | 07 | Day |
| 2024 | Year | 03 | Month | 04 | Day |
| 2024 | Year | 03 | Month | 04 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000061362